Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder - PubMed (original) (raw)
Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder
Robert E McCullumsmith et al. Neuropsychopharmacology. 2002 Mar.
Abstract
Because abnormalities of glutamatergic neurotransmission in psychiatric illness are likely not limited to glutamate receptor expression, we investigated expression of excitatory amino acid transporters (EAATs) in the striatum. The EAATs, normally expressed in both glia (EAAT1 and EAAT2) and neurons (EAAT3 and EAAT4), have previously been implicated in Huntington's disease, amyotrophic lateral sclerosis, and schizophrenia. In this study, we investigated striatal expression of transcripts encoding EAATs in tissue from mood disordered and schizophrenic subjects. With probes designed for the human EAAT1, EAAT2, EAAT3, and EAAT4 transcripts, we performed in situ hybridization and detected decreased expression of EAAT3 and EAAT4 transcripts in the striatum in bipolar disorder. We also detected decreased EAAT3 transcript expression in schizophrenia and decreased EAAT4 transcript expression in major depressive disorder. These results suggest that changes in striatal transporter mRNA expression are restricted to neuronal EAATs and extend the body of evidence implicating abnormal glutamatergic neurotransmission in schizophrenia and mood disorders.
Similar articles
- Neuronal glutamate transporter EAAT4 is expressed in astrocytes.
Hu WH, Walters WM, Xia XM, Karmally SA, Bethea JR. Hu WH, et al. Glia. 2003 Oct;44(1):13-25. doi: 10.1002/glia.10268. Glia. 2003. PMID: 12951653 - Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia.
Smith RE, Haroutunian V, Davis KL, Meador-Woodruff JH. Smith RE, et al. Am J Psychiatry. 2001 Sep;158(9):1393-9. doi: 10.1176/appi.ajp.158.9.1393. Am J Psychiatry. 2001. PMID: 11532723 - Expression of excitatory amino acid transporter interacting protein transcripts in the thalamus in schizophrenia.
Huerta I, McCullumsmith RE, Haroutunian V, Giménez-Amaya JM, Meador-Woodruff JH. Huerta I, et al. Synapse. 2006 Jun 1;59(7):394-402. doi: 10.1002/syn.20250. Synapse. 2006. PMID: 16485262 - Changes in the expression of the glutamate transporter EAAT3/EAAC1 in health and disease.
Bianchi MG, Bardelli D, Chiu M, Bussolati O. Bianchi MG, et al. Cell Mol Life Sci. 2014 Jun;71(11):2001-15. doi: 10.1007/s00018-013-1484-0. Epub 2013 Oct 26. Cell Mol Life Sci. 2014. PMID: 24162932 Free PMC article. Review. - SLC1 glutamate transporters and diseases: psychiatric diseases and pathological pain.
Nakagawa T, Kaneko S. Nakagawa T, et al. Curr Mol Pharmacol. 2013 Jul;6(2):66-73. doi: 10.2174/18744672113069990033. Curr Mol Pharmacol. 2013. PMID: 23876150 Review.
Cited by
- The Impacts of Adolescent Cannabinoid Exposure on Striatal Anxiety- and Depressive-Like Pathophysiology Are Prevented by the Antioxidant _N_-Acetylcysteine.
De Felice M, Szkudlarek HJ, Uzuneser TC, Rodríguez-Ruiz M, Sarikahya MH, Pusparajah M, Galindo Lazo JP, Whitehead SN, Yeung KK, Rushlow WJ, Laviolette SR. De Felice M, et al. Biol Psychiatry Glob Open Sci. 2024 Jul 20;4(6):100361. doi: 10.1016/j.bpsgos.2024.100361. eCollection 2024 Nov. Biol Psychiatry Glob Open Sci. 2024. PMID: 39257692 Free PMC article. - The Importance of α-Klotho in Depression and Cognitive Impairment and Its Connection to Glutamate Neurotransmission-An Up-to-Date Review.
Pańczyszyn-Trzewik P, Czechowska E, Stachowicz K, Sowa-Kućma M. Pańczyszyn-Trzewik P, et al. Int J Mol Sci. 2023 Oct 17;24(20):15268. doi: 10.3390/ijms242015268. Int J Mol Sci. 2023. PMID: 37894946 Free PMC article. Review. - Dysfunction of EAAT3 Aggravates LPS-Induced Post-Operative Cognitive Dysfunction.
Wang XY, Liu WG, Hou AS, Song YX, Ma YL, Wu XD, Cao JB, Mi WD. Wang XY, et al. Membranes (Basel). 2022 Mar 11;12(3):317. doi: 10.3390/membranes12030317. Membranes (Basel). 2022. PMID: 35323793 Free PMC article. - Machine Learning algorithm unveils glutamatergic alterations in the post-mortem schizophrenia brain.
De Rosa A, Fontana A, Nuzzo T, Garofalo M, Di Maio A, Punzo D, Copetti M, Bertolino A, Errico F, Rampino A, de Bartolomeis A, Usiello A. De Rosa A, et al. Schizophrenia (Heidelb). 2022 Feb 25;8(1):8. doi: 10.1038/s41537-022-00231-1. Schizophrenia (Heidelb). 2022. PMID: 35217646 Free PMC article. - Astrocytes in Neuropsychiatric Disorders: A Review of Postmortem Evidence.
Zhang X, Alnafisah RS, Hamoud AA, Shukla R, McCullumsmith RE, O'Donovan SM. Zhang X, et al. Adv Neurobiol. 2021;26:153-172. doi: 10.1007/978-3-030-77375-5_8. Adv Neurobiol. 2021. PMID: 34888835 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical